Arcus Biosciences, Inc.
RCUS· NYSE
Released Aug 6, 2018, after the close
10-Q filed Aug 6, 2018, 37 days after period end · 0001564590-18-019459
| Metric | Q2 2018 | Q2 2017 |
|---|---|---|
| Revenue | $1.25M | — |
| Net Income | -$13.53M | -$9.55M |
| EPS Diluted | -$0.32 | -$5.64 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Arcus Biosciences, Inc. · CIK 1724521 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Jun 30, 2018 · filed Aug 6, 2018 · 37 d after period end
+3.3% from the close of Aug 6, 2018 to the close of Aug 7, 2018, the first after the release.